She maintained her weight loss 18 months post-treatment with ease
PlexusDx also offers GLP-Squared dual-compound therapy combining semaglutide and tirzepatide for enhanced results
The trade-off is randomization: participants may be assigned to placebo or a lower dose arm, and the protocol imposes constraints on concurrent medications and lifestyle modifications that may not reflect individual patient circumstances
Related: Can You Ask If Someone's Taking a GLP-1
In-person and telehealth appointments are available
Among 21,822 people of European ancestry, we required participants to have complete data needed to construct the target phenotype and GWAS covariates (that is, data available for pre-treatment weight, post-treatment weight, drug type, dosage, time on treatment and factors such as age, sex and height), resulting in 18,488 participants